Evolus, Inc. (EOLS) Recent IPO
EOLS Stock Chart More Charts
EOLS Price/Volume Stats
| Current price | $19.36 |
| Prev. close | $16.89 |
| Day low | $16.63 |
| Day high | $19.69 |
| 50-day MA | $10.24 |
| 200-day MA | $0.00 |
| 52-week high | $19.70 |
| 52-week low | $6.75 |
| Volume | 489,156 |
| Avg. volume | 231,913 |
| Dividend yield | N/A |
| Market Cap | 457.67M |
EOLS Returns
| 1-mo | 141.85% |
| 3-mo | 60.13% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
| 2013 | N/A |
Evolus, Inc. (EOLS) Company Bio
Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is based in Irvine, California.
Loading social stream, please wait...